Using e-cigarettes to help smokers with serious mental illness reduce smoking
Official title: Effectiveness and Impact of Counseling Enhanced Using Electronic Cigarettes for Harm Reduction in People With Serious Mental Illness
Run by NYU Langone Health · NCT05815199 · Data updated 2026-11-12
This study is testing if e-cigarettes can help people with serious mental illness cut down on smoking compared to traditional nicotine replacement therapies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | November 13, 2023 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT05815199 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 21 and older who smoke at least five combustible cigarettes per day and have a diagnosis of serious mental illness.
✕Probably not a fit
Patients who are currently attempting to quit smoking or have used other forms of tobacco in the past two weeks may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This open-label, randomized controlled trial aims to evaluate the effectiveness of e-cigarettes compared to nicotine replacement therapy in reducing combustible cigarette smoking among individuals diagnosed with serious mental illness. Participants will receive harm-reduction counseling and Ecological Momentary Intervention text messaging to support their smoking reduction efforts. The study will involve individuals who smoke at least five cigarettes per day and are interested in reducing their smoking without necessarily quitting completely. The trial will assess the impact of these interventions on smoking behavior over a specified period.
Why it matters
Potential benefit: If successful, this approach could provide a viable harm reduction strategy for smokers with serious mental illness, potentially leading to improved health outcomes.
How similar studies have gone: Other studies have explored harm reduction strategies for smoking, but the specific use of e-cigarettes in this population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Currently smokes 5 or more CPD * Willingness and ability to provide informed consent * Age of at least 21 years * Has SMI diagnosis (such as Schizophrenia, Schizoaffective disorders, Bipolar disorder, Depressive disorders, Trauma and stressor related disorders etc.) as determined using the MINI tool * Interested in reducing CC smoking but not necessarily trying to quit * Own a mobile phone or have regular access to a mobile phone * Able to provide an additional contact to improve follow-up rates Exclusion Criteria: * Is pregnant or breastfeeding * Used tobacco other than CC in the past 2 weeks (e.g., EC, cigarillo) * Currently engaged in an attempt to quit CC * Change in dose of their psychotropic medication(s) in the last 30 days * Meeting DSM-V criteria for current alcohol or substance use disorder except for nicotine use disorder and active mild alcohol or substance use disorders. * Past month suicidal ideation/suicide attempt and/or psychiatric hospitalization in the last 30 days
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Omar El-Shahawy — NYU Langone Health
- Study coordinator: Omar El-Shahawy
- Email: Omar.ElShahawy@nyulangone.org
- Phone: 646-501-3587
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Choice-based harm-reduction sampling to help people not ready to quit smoking
This project will test whether letting smokers who aren't ready to quit choose and try a harm-reduction product (an e-cigarette or a nicotine pouch) leads to less cigarette use over six months than giving a nicotine patch plus lozenge.
-
How a very-low-nicotine cigarette standard and product prices affect illegal cigarette buying
This study will test whether requiring very-low-nicotine cigarettes and changing e-cigarette or illegal cigarette prices changes illegal cigarette buying and use of alternatives among adult smokers and dual users.
-
How different tobacco tax plans and availability of regular versus low-nicotine cigarettes affect what smokers buy in a virtual marketplace
This project tests whether four different tobacco tax proposals and the presence or absence of regular (normal-nicotine) cigarettes change purchasing choices among adult daily smokers in a simulated marketplace.
-
Quit-smoking support for fathers of sick children
This project will try a proactive program of brief advice, free nicotine replacement sampling, and smartphone counselling to help fathers of sick children stop smoking.
-
Varenicline-based approach to help Veterans who smoke see if they can reduce smoking and try to quit
This study tests whether varenicline, plus motivational support, helps Veterans who aren’t ready to quit reduce smoking and make quit attempts.
-
Evaluating nicotine pouches for quitting smoking
This study is testing if tobacco-free nicotine pouches can help smokers switch from cigarettes by trying out different nicotine levels over 28 days.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.